November 17, 2020 Sen. Rob Portman (R-Ohio) told CNBC on Tuesday that he enrolled in Johnson & Johnson’s COVID-19 vaccine clinical trial 12 days ago, CNBC reports. Portman told CNBC’s “Squawk Box” that he signed up for the clinical trial because he wanted to demonstrate that vaccines are important to ending the ongoing pandemic. “The […]

FAIRLESS HILLS, Pa.—Johnson & Johnson is ending sales of its iconic talc-based Johnson’s Baby Powder in the U.S. and Canada, where demand has dwindled amid thousands of lawsuits claiming it has caused cancer. The world’s biggest maker of health care products said Tuesday the talc-based powder will still be sold outside the U.S. and Canada. […]

AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday. AstraZeneca, one of the leading vaccine developers, paused its U.S. trial on Sept. 6 after a report of a serious neurological […]

Johnson & Johnson agreed to buy Momenta Pharmaceuticals Inc for about $6.5 billion on Wednesday, to bolster its portfolio of drugs for hard-to-treat autoimmune diseases. The acquisition, latest in a recent spate of healthcare deals, comes just days after France’s Sanofi struck a $3.7 billion deal to buy Principia Biopharma Inc for its pipeline of […]

A team of researchers in Louisiana has proposed a method of combating the coronavirus: issuing booster doses of the measles, mumps and rubella (MMR) vaccine, CNN reported.  The MMR vaccine is a “live vaccine,” using highly weakened versions of the measles, mumps and rubella viruses to provide protection to the immune system that goes beyond just […]